The DOI matches its Crossref record, with a small difference in title or year; 7 of the 7 references it cites were found in a registry or an index.
Persistent Symptoms in Patients After Acute COVID-19
Open accessAbstract
case rate of 587 per 100 000.The crude COVID-19 death rate in prisons was 39 deaths per 100 000 prisoners, which was higher than the US population rate of 29 deaths per 100 000 (Table).However, individuals aged 65 years or older comprised a smaller share of the prison population than of the US population (3% vs 16%, respectively) and accounted for 81% of COVID-19 deaths in the US population.The Table provides a standardized calculation showing that the adjusted death rate in the prison population was 3.0 times higher than would be expected if the age and sex distributions of the US and prison populations were equal.The Figure displays the daily trends in cumulative, confirmed cases of COVID-19 in state and federal prisons and the US population from March 31, 2020, to June 6, 2020.The COVID-19 case rate was initially lower in prisons but surpassed the US population on April 14, 2020.The mean daily case growth rate was 8.3% per day in prisons and 3.4% per day in the US population.Discussion | COVID-19 case rates have been substantially higher and escalating much more rapidly in prisons than in the US population.One limitation of the study is that it relied on officially reported data, which may be subject to inaccuracies and reporting delays, but are the only data available.Comprehensive data on testing rates were not available, and testing rates in both prisons and the overall population were uneven, with many facilities testing no prisoners or only symptomatic persons.2,5 Mass testing in select prisons revealed wide COVID-19 outbreaks, with infection rates exceeding 65% in several facilities. 2 Reported case rates for prisoners therefore likely understated the true prevalence of COVID-19 in prisons.A second limitation is that departments of corrections generally did not report demographic data on decedents, and therefore we could not adjust death rates to account for race/ ethnicity and comorbidity.This study focused on prisons but did not include jails or other detention facilities where there have been notable COVID-19 outbreaks.Although some facilities did engage in efforts to control outbreaks, the findings suggest that overall, COVID-19 in US prisons is unlikely to be contained without implementation of more effective infection control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, what emerges from preliminary data is the negative impact of long COVID on quality of life and its effects on patient work ability and social relationships [1,4,19].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“The high incidence of long COVID within our cohort was similar to that previously reported: more than half of patients reported symptoms lasting more than 2 months after symptom onset [4,5,16,18,19].”
From Female gender is associated with long COVID syndrome: a prospective cohort study (2022) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
Post-COVID-19 global health strategies: the need for an interdisciplinary approach
Gemelli Against COVID-19 Post-Acute Care Study Group, Landi, F., Gremese, E., Bernabei, R., Fantoni, M., Gasbarrini, A., Settanni, C. R., Benvenuto, F., Bramato, G., Carfì, A., et al. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01616-x · Cited by 269
Self-citationThe New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection,
Landi, F., Barillaro, C., Bellieni, A., Brandi, V., Carfì, A., D'Angelo, M., Fusco, D., Landi, G., Monaco, M. R. L., Martone, A. M., et al. (2020) · The journal of nutrition health & aging · doi:10.1007/s12603-020-1356-x · Cited by 145
Self-citationMeasuring symptomatic and functional recovery in patients with community-acquired pneumonia
Metlay, J. P., Fine, M. J., Schulz, R., Marrie, T. J., Coley, C. M., Kapoor, W. N., & Singer, D. E. (1997) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1997.00074.x · Cited by 129
Cited by
Sorted by citations
Items 201–300 of 1,005
Long COVID and chronic COVID syndromes
Halpin, S. J., O’Connor, R. J., & Sivan, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26587 · Cited by 172
“Our results are comparable to the Italian study that followed‐up 143 individuals 7 weeks postdischarge.(2) Garg et al.”
ResultLong-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge
Maestre-Muñiz, M. M., Arias, Á., Vázquez, E. M., Martín-Toledano, M., López‐Larramona, G., Ruíz-Chicote, A. M., Nieto-Sandoval, B., & Lucendo, A. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132945 · Cited by 176
“and psychological symptoms, leading to impaired health-related quality of life [5,7,8,10].”
BackgroundLong-term COVID-19 symptoms in a large unselected populationPreprint
Cirulli, E. T., Barrett, K. M. S., Riffle, S., Bolze, A., Neveux, I., Dabe, S., Grzymski, J. J., Lu, J. T., & Washington, N. L. (2020) · medRxiv · doi:10.1101/2020.10.07.20208702 · Cited by 174
Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care
Parker, A. M., Brigham, E. P., Connolly, B. A., McPeake, J. M., Agranovich, A. V., Kenes, M. T., Casey, K. S., Reynolds, C., Schmidt, K. F. R., Kim, S. Y., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00385-4 · Cited by 178
COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review
Poenaru, S., Abdallah, S. J., Corrales‐Medina, V., & Cowan, J. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361211009385 · Cited by 167
Long-term neurological manifestations of COVID-19: prevalence and predictive factors
Pilotto, A., Cristillo, V., Piccinelli, S. C., Zoppi, N., Bonzi, G., Sattin, D., Schiavolin, S., Raggi, A., Canale, A., Gipponi, S., et al. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05586-4 · Cited by 170
“These findings extended the earlier works of Carfi [7] and Goertz [8], reporting a high persistence of respiratory symptoms and fatigue in”
ResultNeurological and cognitive sequelae of COVID-19: a four month follow-up.
Mattioli, F., Stampatori, C., Righetti, F., Sala, E., Tomasi, C., & De Palma, G. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10579-6 · Cited by 160
Gut microbiota: A new insight into lung diseases
Ma, P.-J., Wang, M., & Wang, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113810 · Cited by 171
Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19
Dhawan, R. T., Gopalan, D., Howard, L., Vicente, A., Park, M., Manalan, K., Wallner, I., Marsden, P., Dave, S., Branley, H. M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30407-0 · Cited by 171
Tracking COVID-19 using online search
Lampos, V., Majumder, M. S., Yom-Tov, E., Edelstein, M., Moura, S., Hamada, Y., Rangaka, M. X., McKendry, R. A., & Cox, I. J. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00384-w · Cited by 164
Gyöngyösi, M., Alcaide, P., Asselbergs, F. W., Brundel, B. J. J. M., Camici, G. G., Martins, P. A. D. C., Ferdinandy, P., Fontana, M., Girão, H., Gnecchi, M., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac115 · Cited by 175
Return-to-work, disabilities and occupational health in the age of COVID-19
Godeau, D., Petit, A., Richard, I., Roquelaure, Y., & Descatha, A. (2021) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.3960 · Cited by 153
Buonsenso, D., Pujol, F. E., Munblit, D., Pata, D., McFarland, S., & Simpson, F. K. (2022) · Future Microbiology · doi:10.2217/fmb-2021-0285 · Cited by 168
Finlay, J. B., Brann, D. H., Hachem, R. A., Jang, D. W., Oliva, A. D., Ko, T., Gupta, R., Wellford, S. A., Moseman, E. A., Jang, S. S., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.add0484 · Cited by 174
Seighali, N., Abdollahi, A., Shafiee, A., Amini, M. J., Athar, M. M. T., Safari, O., Faghfouri, P., Eskandari, A., Rostaii, O., Salehi, A. H., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-023-05481-6 · Cited by 213
“Post-COVID-19 syndrome, which pertains to the persistence of symptoms beyond the expected recovery period, has become a burgeoning concern and has been correlated with the emergence of mental health afflictions such as depression and anxiety [2].”
BackgroundS1-Leitlinie Post-COVID/Long-COVID
Koczulla, A. R., Ankermann, T., Behrends, U., Berlit, P., Böing, S., Brinkmann, F., Franke, C., Glöckl, R., Gogoll, C., Hummel, T. R., et al. (2021) · Pneumologie · doi:10.1055/a-1551-9734 · Cited by 164
“[195] Carfi A, Bernabei R, Landi F et al.”
BackgroundAburto, J. M., Kashyap, R., Schöley, J., Angus, C., Ermisch, J., Mills, M. C., & Dowd, J. B. (2021) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2020-215505 · Cited by 159
Romero-Duarte, Á., Rivera‐Izquierdo, M., de Alba, I. G.-F., Pérez-Contreras, M., Fernández‐Martínez, N. F., Ruiz-Montero, R., Serrano-Ortiz, Á., Ortiz-González-Serna, R., Salcedo-Leal, I., Jiménez-Mejías, E., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02003-7 · Cited by 161
“All reported series concur that dyspnoea and fatigue are the most frequent SPS after COVID-19 [12, 18, 20, 30].”
BackgroundInfluentialGarcía‐Abellán, J., Padilla, S., Fernández‐González, M., García, J. A., Agulló, V., Galera, M. A., Ruiz, S., Galiana, A., Gutiérrez, F., & Masiá, M. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01083-7 · Cited by 157
CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after Hospital Discharge
Vijayakumar, B., Tonkin, J., Devaraj, A., Philip, K. E. J., Orton, C. M., Desai, S. R., & Shah, P. L. (2021) · Radiology · doi:10.1148/radiol.2021211746 · Cited by 159
European Respiratory Society statement on long COVID follow-up
Antoniou, K. M., Vasarmidi, E., Russell, A., Andréjak, C., Crestani, B., Delcroix, M., Dinh‐Xuan, A. T., Poletti, V. E., Sverzellati, N., Vitacca, M., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02174-2021 · Cited by 166
Post-COVID-19 functional status six-months after hospitalization
Taboada, M., Cariñena, A., Moreno, E., Rodríguez, N., Domínguez, M. J., Casal, A., Riveiro, V., Diaz‐Vieito, M., Valdés, L., Álvarez, J., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.12.022 · Cited by 167
“N Engl J Med 2003; 348 (February 20(8)):683–93.”
Drake, T. M., Riad, A., Fairfield, C. J., Egan, C., Knight, S. R., Pius, R., Hardwick, H., Norman, L., Shaw, C. A., McLean, K. A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00799-6 · Cited by 160
What can we learn from brain autopsies in COVID-19?
Mukerji, S. S., & Solomon, I. H. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135528 · Cited by 160
Stavem, K., Ghanima, W., Olsen, M. K., Gilboe, H. M., & Einvik, G. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18042030 · Cited by 163
“Fatigue was reported by 60–70% on average 48 days after hospital discharge [12], and by 53% of hospitalized patients on average 36 days after discharge (60 days after symptom start) (n = 143) [13].”
BackgroundBilich, T., Nelde, A., Heitmann, J. S., Maringer, Y., Roerden, M., Bauer, J., Rieth, J., Wacker, M., Peter, A., Hörber, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf7517 · Cited by 150
Jennings, G., Monaghan, A., Feng, X., Mockler, D., & Romero‐Ortuño, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245913 · Cited by 156
“Carfi [12] 20 July Italy 143 X = 57 37% Inpatient (+ICU) 9”
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings
Sneller, M. C., Liang, C., Marques, A. R., Chung, J. Y., Shanbhag, S. M., Fontana, J. R., Raza, H., Okeke, O., Dewar, R. L., Higgins, B. P., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m21-4905 · Cited by 160
Iqbal, A., Iqbal, K., Ali, S. A., Azim, D., Farid, E., Baig, M. D., Arif, T. B., & Raza, M. (2021) · Cureus · doi:10.7759/cureus.13080 · Cited by 155
“An Italian study revealed that 32% of the previously hospitalized patients complained of the persistence of one or two COVID-19-associated symptoms, while 55% reported three or more symptoms even two months after being discharged [7].”
BackgroundRao, S., Lee, G. M., Razzaghi, H., Lorman, V., Mejías, A., Pajor, N. M., Thacker, D., Webb, R. D., Dickinson, K., Bailey, L. C., et al. (2022) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2022.2800 · Cited by 152
The “post‐COVID” syndrome: How deep is the damage?
Garg, P., Arora, U., Kumar, A., & Wig, N. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26465 · Cited by 166
“The prevalence of residual symptoms in their cohort is much higher than estimates of 35% among out-patient, 2 but comparable with recent cohorts of hospitalized patients (87%).(3) Apart from fatigue, a significant proportion of their patients suffer from persistent dyspnea and neuropsychological symptoms.”
ResultNehme, M., Braillard, O., Chappuis, F., Courvoisier, D. S., Guessous, I., & CoviCare Study Team (2021) · Annals of Internal Medicine · doi:10.7326/m21-0878 · Cited by 151
“Recent studies show persistent symptoms after hospitalization (7, 9) and in outpatient settings (10–14).”
BackgroundCardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up
Clavario, P., Marzo, V. D., Lotti, R., Bárbara, C., Porcile, A., Russo, C., Beccaria, F., Bonavia, M., Bottaro, L. C., Caltabellotta, M., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.07.033 · Cited by 155
Cenko, E., Badimón, L., Bugiardini, R., Claeys, M. J., Luca, G. D., de Wit, C., Dérumeaux, G., Dorobanţu, M., Duncker, D. J., Eringa, E. C., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab298 · Cited by 152
Evolving phenotypes of non-hospitalized patients that indicate long COVID
Estiri, H., Strasser, Z. H., Brat, G. A., Semenov, Y. R., Aaron, J. R., Agapito, G., Albayrak, A., ALESSIANI, M., Amendola, D. F., Anthony, L. L. L. J., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02115-0 · Cited by 155
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview
Deumer, U.-S., Varesi, A., Floris, V., Savioli, G., Mantovani, E., López-Carrasco, P., Rosati, G. M., Prasad, S., & Ricevuti, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204786 · Cited by 167
Kayaaslan, B., Eser, F., Kalem, A. K., Kaya, G., Kaplan, B., Kacar, D., Hasanoğlu, İ., Coşkun, B., & Güner, R. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27198 · Cited by 156
“Several other studies also reported fatigue as the most common symptom.(3,4,11,12,14,16) COVID‐19 can lead to pulmonary complications such as fibrosis, cough, and bronchiectasis.”
BackgroundResultFabbri, L., Moss, S., Khan, F., Chi, W., Xia, J., Robinson, K. A., Smyth, A. R., Jenkins, G. R., & Stewart, I. D. (2022) · Thorax · doi:10.1136/thoraxjnl-2021-218275 · Cited by 166
T Cell Metabolism in Infection
Wik, J. A., & Skålhegg, B. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840610 · Cited by 158
Post-COVID syndrome and suicide risk
Sher, L. (2021) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcab007 · Cited by 148
Why the Patient-Made Term 'Long Covid' is needed
Perego, E., Callard, F. J., Stras, L., Melville-Jóhannesson, B., Pope, R., & Alwan, N. A. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16307.1 · Cited by 166
Post covid 19 pulmonary fibrosis. Is it real threat?
Rai, D. K., Sharma, P., & Kumar, R. K. (2020) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2020.11.003 · Cited by 148
Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation
Venturelli, S., Benatti, S. V., Casati, M., Binda, F., Zuglian, G., Imeri, G., Conti, C., Biffi, A. M., Spada, M. S., Bondi, E., et al. (2021) · Epidemiology and Infection · doi:10.1017/s0950268821000145 · Cited by 146
“Anecdotal evidence is mounting about the so-called “long- COVID”: a hard-to-define syndrome, with some patients complaining of symptoms many months following recovery from the acute phase [5-9].”
BackgroundInfluentialStewart, I. D., Jacob, J., George, P. M., Molyneaux, P. L., Porter, J. C., Allen, R. J., Aslani, S., Baillie, J. K., Barratt, S. L., Beirne, P., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202203-0564oc · Cited by 147
Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis
Yin, J.-X., Agbana, Y. L., Sun, Z., Fei, S.-W., Zhao, H.-Q., Zhou, X., Chen, J., & Kassegne, K. (2023) · Infectious Diseases of Poverty · doi:10.1186/s40249-023-01086-z · Cited by 161
“1% of discharged patients with COVID19 still experience at least one symptom, and 55% experience three or more symptoms, such as dyspnea, chest pain, fatigue, and reduced quality of life [10].”
BackgroundBaig, A. M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00725 · Cited by 147
COVID-19 and Myositis: What We Know So Far
Saud, A., Naveen, R., Aggarwal, R., & Gupta, L. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-01023-9 · Cited by 145
Returning to physical activity after covid-19
Salman, D., Vishnubala, D., Feuvre, P. A. L., Beaney, T. E., Korgaonkar, J., Majeed, A., & McGregor, A. H. (2021) · BMJ · doi:10.1136/bmj.m4721 · Cited by 150
The concept of “fatigue” in tackling covid-19
Michie, S., West, R., & Harvey, N. (2020) · BMJ · doi:10.1136/bmj.m4171 · Cited by 141
Petito, E., Falcinelli, E., Paliani, U., Cesari, E., Vaudo, G., Sebastiano, M., Cerotto, V., Guglielmini, G., Gori, F., Malvestiti, M., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa756 · Cited by 141
“However, NET biomarkers did not seem to decrease to normal control levels, suggesting that some degree of neutrophil activation might persist after recovery, possibly contributing to the continued inflammatory reaction and long term sequelae which start to emerge in these patients [44,45].”
BackgroundESCMID rapid guidelines for assessment and management of long COVID
Yelin, D., Moschopoulos, C. D., Margalit, I., Gkrania‐Klotsas, E., Landi, F., Stahl, J. ‐., & Yahav, D. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.02.018 · Cited by 145
Self-citationProlonged and Late-Onset Symptoms of Coronavirus Disease 2019
Miyazato, Y., Morioka, S., Tsuzuki, S., Akashi, M., Osanai, Y., Tanaka, K., Terada, M., Suzuki, M., Kutsuna, S., Saito, S., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa507 · Cited by 138
“Although previous studies have investigated post-COVID-19 symptoms 1421 days after diagnosis [1] and approximately 60 days after symptom onset [2], no studies have shown a longer progression of symptoms than these studies.”
ResultRehabilitation and COVID-19: the Cochrane Rehabilitation 2020 rapid living systematic review
Ceravolo, M. G., Arienti, C., Alessandro de, S. I. R. E., Andrenelli, E., Negrini, F., Lazzarini, S. G., Patrini, M., & Négrini, S. (2020) · European Journal of Physical and Rehabilitation Medicine · doi:10.23736/s1973-9087.20.06501-6 · Cited by 140
SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
El‐Boghdadly, K., Cook, T. M., Goodacre, T., Kua, J., Blake, L., Denmark, S., McNally, S., Mercer, N. S. G., Moonesinghe, R., & Summerton, D. J. (2021) · Anaesthesia · doi:10.1111/anae.15464 · Cited by 141
“In a cohort study of 1655 hospitalised patients in China followed up at 6 months [10] and another of 143 patients in Italy followed up at 9 weeks [11], 76% and”
BackgroundInterleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19
Kappelmann, N., Dantzer, R., & Khandaker, G. M. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105295 · Cited by 139
“…(e.g., cough, shortness of breath, chest tightness) and neuropsychiatric (e.g., fatigue, cognitive dysfunction, sleeping difficulties, depression, and anxiety) (Carfì et al., 2020; Davis et al., 2020; Huang et al., 2021; Lopez-Leon et al., 2021; Mazza et al., 2020; Taquet et al., 2021, 2020).”
Cardiac involvement in the long-term implications of COVID-19
Satterfield, B. A., Bhatt, D. L., & Gersh, B. J. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00631-3 · Cited by 138
The autonomic aspects of the post-COVID19 syndrome
Dotan, A., David, P., Arnheim, D., & Shoenfeld, Y. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103071 · Cited by 139
Long-term gastrointestinal outcomes of COVID-19
Xu, E., Xie, Y., & Al‐Aly, Z. (2023) · Nature Communications · doi:10.1038/s41467-023-36223-7 · Cited by 141
Rando, H. M., Bennett, T. D., Byrd, J. B., Bramante, C. T., Callahan, T. J., Chute, C. G., Davis, H., Deer, R., Gagnier, J. J., Koraishy, F. M., et al. (2021) · medRxiv · doi:10.1101/2021.03.20.21253896 · Cited by 149
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. M., Викторович, А. М., Alexandrova, L. M., Анциферова, А. А., Dm, A., Ахмеджанов, Н. М., Balanova, Y. А., et al. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3235 · Cited by 197
Interventions for the management of long covid (post-covid condition): living systematic review
Zeraatkar, D., Ling, M., Kirsh, S., Jassal, T., Shahab, M., Movahed, H., Talukdar, J. R., Walch, A., Chakraborty, S. P., Turner, T., et al. (2024) · BMJ · doi:10.1136/bmj-2024-081318 · Cited by 149
Impact of COVID-19 in solid organ transplant recipients
Danziger‐Isakov, L. A., Blumberg, E. A., Manuel, O., & Sester, M. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16449 · Cited by 139
SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress
Chang, R. P., Mamun, A., Dominic, A., & Le, N. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.605908 · Cited by 136
COVID-19: Rethinking the Lockdown Groupthink
Joffe, A. R. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.625778 · Cited by 163
Sex‐based differences in severity and mortality in COVID‐19
Alwani, M. M., Yassin, A. A., Al‐Zoubi, R. M., Aboumarzouk, O. M., Nettleship, J. E., Kelly, D. M., Al-Qudimat, A. R., & Shabsigh, R. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2223 · Cited by 139
Long COVID and Health Inequities: The Role of Primary Care
Berger, Z. D., Jesus, V. V. A. D., Assoumou, S. A., & Greenhalgh, T. (2021) · Milbank Quarterly · doi:10.1111/1468-0009.12505 · Cited by 133
Tejerina, F., Catalán, P., Rodríguez‐Grande, C., Adán‐Jiménez, J., Rodríguez, C., Muñóz, P., Aldámiz‐Echevarría, T., Díez, C., Latorre, L. P., Fanciulli, C., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07153-4 · Cited by 135
Li, J., Zhou, Y., Ma, J., Zhang, Q., Shao, J., Liang, S., Yu, Y., Li, W., & Wang, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01640-z · Cited by 150
Saygılı, A. (2021) · Applied Soft Computing · doi:10.1016/j.asoc.2021.107323 · Cited by 139
“Also, shortness of breath, muscle or body aches, headache, loss of taste or smell, sore throat, and diarrhea are other common symptoms [2].”
BackgroundFrom ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
Michalski, J. E., Kurche, J. S., & Schwartz, D. A. (2021) · Translational research · doi:10.1016/j.trsl.2021.09.001 · Cited by 139
“Up to two-thirds of individuals recovering from severe COVID-19 report persistent pulmonary symptoms, most commonly dyspnea, several months after their acute illness and have dramatically reduced functional capacity as measured by the 6-minute walk test.(25-30) These data parallel our existing knowledge of impairments…”
Almeida, K. D. O., Alves, I. G. N., de Queiroz, R. S., de Castro, M. R., Gomes, V. A., Santos, F. C., Brites, C. R., & Neto, M. G. (2022) · Chronic Illness · doi:10.1177/17423953221089309 · Cited by 136
“Twelve studies evaluated only physical function,15–17,19–21,33,37,43,45,47,48 two studies evaluate only activities of daily living(24,49) and eighth only the health-related quality of life.(23,29,30,32,39,40,42,46) Five studies evaluated physical function and activities of daily living.”
BackgroundPeluso, M. J., Kelly, J. D., Lu, S., Goldberg, S. A., Davidson, M. C., Mathur, S., Durstenfeld, M. S., Spinelli, M. A., Hoh, R., Tai, V., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab640 · Cited by 128
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
von Meijenfeldt, F. A., Havervall, S., Adelmeijer, J., Lundström, A., Magnusson, M., Mackman, N., Thålin, C., & Lisman, T. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003968 · Cited by 131
Vaes, A. W., Goërtz, Y. M. J., Herck, M. V., Machado, F. V. C., Meys, R., Delbressine, J. M., Houben‐Wilke, S., Gaffron, S., Maier, D., Burtin, C., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00141-2021 · Cited by 138
“Even though a large proportion recover fully, case reports and several cohort studies have shown that part of the patients have persistent symptoms (for more than 12 weeks after the COVID-19 related infection), such as fatigue, dyspnoea, chest tightness, headache and muscle pain[1-9]Moreover, an impaired functional st…”
Hirschtick, J. L., Titus, A. R., Slocum, E. M., Power, L. E., Hirschtick, R. E., Elliott, M. R., McKane, P., & Fleischer, N. L. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab408 · Cited by 133
Aleebrahim‐Dehkordi, E., Molavi, B., Mokhtari, M., Deravi, N., Fathi, M., Fazel, T., Mohebalizadeh, M., Koochaki, P., Shobeiri, P., & Dehkordi, A. H. (2021) · Transplant Immunology · doi:10.1016/j.trim.2021.101495 · Cited by 133
Pérez‐González, A., Araújo-Ameijeiras, A., Fernández‐Villar, A., Casal, M. C., Poveda, E., Cabrera, J. J., del Campo, V., de Araujo, B. G., Gómez, C., Leiro‐Fernández, V., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07414-x · Cited by 138
Huang, Y., Pinto, M. D., Borelli, J. L., Mehrabadi, M. A., Abrihim, H., Dutt, N. D., Lambert, N., Nurmi, E. L., Chakraborty, R., Rahmani, A. M., et al. (2021) · medRxiv · doi:10.1101/2021.03.03.21252086 · Cited by 131
“These symptoms are reported and recorded in real time which minimizes retrospective recall that has been used in the limited studies to date (4, 9).”
BackgroundVasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study
Sollini, M., Ciccarelli, M., Cecconi, M., Aghemo, A., Morelli, P., Gelardi, F., & Chiti, A. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05084-3 · Cited by 130
One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms
Almufarrij, I., & Munro, K. J. (2021) · International Journal of Audiology · doi:10.1080/14992027.2021.1896793 · Cited by 136
Health‐related quality of life of COVID‐19 patients after discharge: A multicenter follow‐up study
Qu, G., Zhen, Q., Wang, W., Fan, S., Wu, Q., Zhang, C., Li, B., Liu, G., Yu, Y., Li, Y., et al. (2021) · Journal of Clinical Nursing · doi:10.1111/jocn.15733 · Cited by 138
de Miranda, D. A. P., Gomes, S. V., Filgueiras, P. S., Corsini, C. A., Almeida, N. B. F., Silva, R. A., de Medeiros, M. I. V. D. A. R. C., Vilela, R. V., Fernandes, G. D. R., & Grenfell, R. F. Q. (2022) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trac030 · Cited by 137
Sex-Related Differences in Long-COVID-19 Syndrome
Pelà, G. M., Goldoni, M., Solinas, E., Cavalli, C., Tagliaferri, S., Ranzieri, S., Frizzelli, A., Marchi, L., Mori, P. A., Majori, M., et al. (2022) · Journal of Women s Health · doi:10.1089/jwh.2021.0411 · Cited by 139
“6,7 13 We demonstrated that Long-COVID-19 may significantly differ among M and F: F were more symptomatic than M (97% vs. 84%), with a large percentage reporting persistent COVID-19 symptoms, such as dyspnea, fatigue, thoracic pain, palpitations, and sleep disturbances.”
InfluentialWan, E. Y. F., Mathur, S., Zhang, R., Yan, V. K. C., Lai, F. T. T., Chui, C. S. L., Li, X., Wong, C. K. H., Chan, E. W., Yiu, K. H., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvac195 · Cited by 130
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review
Ramadan, M. S., Bertolino, L., Zampino, R., Durante‐Mangoni, E., Durante‐Mangoni, E., Iossa, D., Bertolino, L., Ursi, M. P., D’Amico, F., Karruli, A., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.06.015 · Cited by 131
Cassar, M. P., Tunnicliffe, E. M., Petousi, N., Lewandowski, A. J., Xie, C., Mahmod, M., Samat, A. H. A., Evans, R. A., Brightling, C. E., Ho, L., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101159 · Cited by 132
“As the COVID-19 pandemic has progressed, our understanding of the long-term effects of SARS-CoV-2 infection has evolved [42-44].”
Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
Bisaccia, G., Ricci, F., Recce, V., Serio, A., Iannetti, G., Chahal, A. A., Ståhlberg, M., Khanji, M. Y., Fedorowski, A., & Gallina, S. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8110156 · Cited by 129
“Symptoms characterizing PASC include fatigue, dyspnea, post-exertional malaise, chest pain, and palpitations [7,8].”
BackgroundInfluentialPost-Acute COVID-19 Syndrome and the cardiovascular system: What is known?
Dixit, N. M., Churchill, A., Nsair, A., & Hsu, J. J. (2021) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2021.100025 · Cited by 129
“Carfi [84] 143 60 days Hospitalized Fatigue 53.”
Ashkenazi‐Hoffnung, L., Shmueli, E., Ehrlich, S., Ziv, A., Bar-On, O., Birk, E., Lowenthal, A., & Prais, D. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003285 · Cited by 140
Bai, C., Chotirmall, S. H., Rello, J., Alba, G. A., Ginns, L. C., Krishnan, J. A., Rogers, R., Bendstrup, E. M., Burgel, P., Chalmers, J. D., et al. (2020) · European Respiratory Review · doi:10.1183/16000617.0287-2020 · Cited by 130
Tran, V.-T., Riveros, C., Clepier, B., Desvarieux, M., Collet, C., Yordanov, Y., & Ravaud, P. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab352 · Cited by 130
“According to some studies, from 10% to 70% of them, including many who only had a mild disease, report the presence of symptoms such as fatigue, dyspnea, chest pain, memory problems, and concentration disorders persisting beyond three weeks from the initial onset of symptoms [2-8].”
BackgroundGrist, J. T., Chen, M., Collier, G. J., Raman, B., Eid, G. A., McIntyre, A., Matthews, V., Fraser, E., Ho, L., Wild, J. M., et al. (2021) · Radiology · doi:10.1148/radiol.2021210033 · Cited by 127
Boscolo‐Rizzo, P., Hummel, T. R., Hopkins, C. L., Dibattista, M., Menini, A., Spinato, G., Fabbris, C., Emanuelli, E., D’Alessandro, A., Marzolino, R., et al. (2021) · Rhinology Journal · doi:10.4193/rhin21.249 · Cited by 128
Central Nervous System Manifestations Associated with COVID-19
Divani, A. A., Andalib, S., Biller, J., Napoli, M. D., Moghimi, N., Rubiños, C., Nobleza, C. O., Sylaja, P. N., Toledano, M., Lattanzi, S., et al. (2020) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01079-7 · Cited by 129
Shi, Z., de Vries, H. J., Vlaar, A. P. J., van der Hoeven, J., Boon, R. A., Heunks, L. M. A., Ottenheijm, C. A. C., & Dutch COVID-19 Diaphragm Investigators (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.6278 · Cited by 127
Six month follow-up of self-reported loss of smell during the COVID-19 pandemic
Hopkins, C. L., Šurda, P., Vaira, L. A., Lechien, J. R., Safarian, M., Saussez, S., & Kumar, N. (2020) · Rhinology Journal · doi:10.4193/rhin20.544 · Cited by 132
Quantitative Chest CT Assessment of Small Airways Disease in Post-Acute SARS-CoV-2 Infection
Cho, J. L., Villacreses, R. A., Nagpal, P., Guo, J., Pezzulo, A. A., Thurman, A. L., Hamzeh, N. Y., Blount, R. J., Fortis, S., Hoffman, E. A., et al. (2022) · Radiology · doi:10.1148/radiol.212170 · Cited by 126
Rapid vigilance and episodic memory decrements in COVID-19 survivors
Zhao, S., Shibata, K., Hellyer, P. J., Trender, W. R., Manohar, S., Hampshire, A., & Husain, M. (2021) · Brain Communications · doi:10.1093/braincomms/fcab295 · Cited by 127
Long COVID in the skin: a registry analysis of COVID-19 dermatological duration
McMahon, D. E., Gallman, A. E., Hruza, G. J., Rosenbach, M. A., Lipoff, J. B., Desai, S. R., French, L. E., Lim, H. W., Cyster, J. G., Fox, L. P., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30986-5 · Cited by 123
Orrù, G., Bertelloni, D., Diolaiuti, F., Mucci, F., Giuseppe, M. D., Biella, M., Gemignani, A., Ciacchini, R., & Conversano, C. (2021) · Healthcare · doi:10.3390/healthcare9050575 · Cited by 124
“These results are consistent with the outcomes reported in recent investigations that revealed a reduction in the quality of life of subjects with COVID-19 or long-COVID syndrome [25,27].”
BackgroundResultInfluential
Metadata
- Authors
- Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group
- Affiliations
- Agostino Gemelli University Polyclinic (IT)
- Corresponding author
- Carfì, Angelo
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2020-08-11
- Volume
- 324
- Issue
- 6
- Pages
- 603
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC7349096
- OpenAlex
- W3041493976
- Cited by
- 4,561
- References
- 7
- Citations by year
- 2026: 139 · 2025: 292 · 2024: 495 · 2023: 827 · 2022: 1183 · 2021: 1373 · 2020: 245
- FWCI
- 393.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pennsylvania
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Keywords
- COVID-19 pandemic, long COVID, post-acute symptoms, prisoners, prison population, COVID-19 mortality, COVID-19 case rates, infection control, jails, detention centers, COVID-19 outbreak
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Adult, Aged, Chest Pain, Dyspnea, Fatigue, Female, Follow-Up Studies, Humans, Italy, Male, Middle Aged, Pneumonia, Viral, Coronavirus Infections, Arthralgia, Pandemics, Symptom Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
